Search
PTC Therapeutics Inc
PTCTAdd to Watchlist
65.370USD
-2.630-3.87%
Close 09-18 16:00（ET）
5.45BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-3.87%
5 Days
-1.04%
1 Month
-11.27%
6 Months
-2.54%
Year to Date
-13.94%
1 Year
+8.09%
Key Figures
68.000Open
68.005High
70.73KVolume
LossP/E TTM
24.32P/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
68.000Prev. Close
65.180Low
4.67MTurnover
LossP/E Static
-32.95P/B
0.00%Div Yield TTM
-6.76%ROA
90.87052wk High
0.07Volume Ratio
-363.30MNet Profit
81.47MShares
-2.5443EPS TTM
0.54Beta
--ROE
57.74052wk Low
3.12%Amplitude
91.19%Gross Margin
5.45BMarket Cap
-3.91Reward/Risk
2.52%Risk Rate
More news coming soon, stay tuned...
PTC Therapeutics Inc's Score
0.03vs previous score
Forecast8.00
Financial Health8.56
Technical3.52
Valuation Dimensions9.83
Institutional Confidence10.00
Risk Assessment7.62
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
PTC Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
1.01/0.42
Revenue / Forecast
360.52M/298.96M
PTC Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolPTCT
Number of employees939
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| BlackRock Institutional Trust Company, N.A. | 13.72% |
| RTW Investments L.P. | 9.34% |
| Janus Henderson Investors | 5.85% |
| Vanguard Portfolio Management, LLC | 5.79% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor/Hedge Fund | 44.49% |
| Investment Advisor | 43.10% |
| Hedge Fund | 13.82% |
| Research Firm | 11.91% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of PTC Therapeutics Inc (PTCT)?
The current price of PTC Therapeutics Inc (PTCT) is 65.37.
What is the symbol of PTC Therapeutics Inc?
The ticker symbol of PTC Therapeutics Inc is PTCT.
What is the 52-week high of PTC Therapeutics Inc?
The 52-week high of PTC Therapeutics Inc is 90.87.
What is the 52-week low of PTC Therapeutics Inc?
The 52-week low of PTC Therapeutics Inc is 57.74.
What is the market capitalization of PTC Therapeutics Inc?
The market capitalization of PTC Therapeutics Inc is 5.45B.
Is PTC Therapeutics Inc (PTCT) currently rated as Buy, Hold, or Sell?
According to analysts, PTC Therapeutics Inc (PTCT) has an overall rating of Buy, with a price target of 102.08.
What is the Earnings Per Share (EPS TTM) of PTC Therapeutics Inc (PTCT)?
The Earnings Per Share (EPS TTM) of PTC Therapeutics Inc (PTCT) is -2.54.